Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1798 1
1801 1
1890 1
1893 1
1896 2
1898 1
1903 1
1906 2
1908 4
1910 3
1911 2
1912 1
1913 4
1914 5
1915 1
1916 6
1919 1
1920 5
1921 1
1922 6
1923 6
1924 1
1925 1
1926 10
1927 4
1928 3
1929 2
1931 6
1938 1
1940 4
1944 2
1945 3
1946 8
1947 4
1948 3
1950 1
1951 1
1952 2
1953 1
1954 1
1955 1
1956 1
1957 2
1958 7
1959 1
1960 3
1961 2
1962 3
1963 1
1964 2
1965 1
1966 4
1968 1
1969 2
1970 2
1971 1
1973 2
1974 2
1976 4
1977 5
1978 4
1979 5
1980 4
1981 9
1982 8
1983 4
1984 2
1985 7
1986 7
1987 9
1988 13
1989 11
1990 12
1991 12
1992 31
1993 22
1994 18
1995 17
1996 11
1997 21
1998 27
1999 29
2000 27
2001 30
2002 25
2003 28
2004 29
2005 28
2006 51
2007 58
2008 46
2009 47
2010 51
2011 91
2012 70
2013 75
2014 60
2015 84
2016 68
2017 64
2018 63
2019 58
2020 64
2021 72
2022 80
2023 59
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,670 results

Results by year

Filters applied: . Clear all
Page 1
Guideline of guidelines: management of recurrent urinary tract infections in women.
Kwok M, McGeorge S, Mayer-Coverdale J, Graves B, Paterson DL, Harris PNA, Esler R, Dowling C, Britton S, Roberts MJ. Kwok M, et al. Among authors: paterson dl. BJU Int. 2022 Nov;130 Suppl 3(Suppl 3):11-22. doi: 10.1111/bju.15756. Epub 2022 May 17. BJU Int. 2022. PMID: 35579121 Free PMC article. Review.
Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. De Oliveira DMP, et al. Among authors: paterson dl. Clin Microbiol Rev. 2020 May 13;33(3):e00181-19. doi: 10.1128/CMR.00181-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32404435 Free PMC article. Review.
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. Among authors: paterson dl. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
Achromobacter Infections and Treatment Options.
Isler B, Kidd TJ, Stewart AG, Harris P, Paterson DL. Isler B, et al. Among authors: paterson dl. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01025-20. doi: 10.1128/AAC.01025-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32816734 Free PMC article. Review.
Multidrug-Resistant Bacteria in the Community: An Update.
van Duin D, Paterson DL. van Duin D, et al. Among authors: paterson dl. Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30. Infect Dis Clin North Am. 2020. PMID: 33011046 Free PMC article. Review.
Culture-independent detection systems for bloodstream infection.
Peri AM, Harris PNA, Paterson DL. Peri AM, et al. Among authors: paterson dl. Clin Microbiol Infect. 2022 Feb;28(2):195-201. doi: 10.1016/j.cmi.2021.09.039. Epub 2021 Oct 20. Clin Microbiol Infect. 2022. PMID: 34687856 Review.
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Bassetti M, et al. Among authors: paterson dl. Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058795 Clinical Trial.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Oñate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltrán SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordoñez K, Wang M, Stryjewski ME, Munita JM, Paterson DL, Evans S, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG Jr, Doi Y, van Duin D, Satlin MJ; Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators. Reyes J, et al. Among authors: paterson dl. Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9. Lancet Microbe. 2023. PMID: 36774938 Free PMC article.
1,670 results